{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:01:31Z","timestamp":1790089291094,"version":"4.0.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine association between maternal serum uric acid (UA) measured during gestational 4\u201324 weeks and the subsequent development of hypertensive disorders of pregnancy (HDP) in a large Chinese cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This historical cohort study included 84,298 singleton pregnancies registered at Shanghai First Maternity and Infant Hospital (2013\u20132022). Serum UA was measured before 24 weeks of gestation. Participants with pre-existing hypertension or incomplete data were excluded. Generalized additive models (GAMs) and multivariable logistic regression analyses were used to assess nonlinear and independent associations between UA levels (quartiles and continuous values) and risks of gestational hypertension (GH), preeclampsia (PE), and overall HDP cases, adjusting for maternal age, pre-pregnancy BMI, education, and glucose metabolism disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      UA levels were consistently higher among women who later developed HDP than in normotensive pregnancies throughout gestational weeks 4\u201324. Higher UA concentrations consistently associated with an increased risk of HDP diseases, the top UA quartile showed the strongest associations with GH (1.82, 1.59\u20132.08), PE (1.67, 1.48\u20131.89), and total HDP (1.77, 1.61\u20131.94). GAM analyses revealed enhanced relation of UA to HDP occurrence from the 4\n                      <jats:sup>th<\/jats:sup>\n                      week to 24\n                      <jats:sup>th<\/jats:sup>\n                      week, and showed specific patterns in GH\/PE, predictive strength of maternal UA increased with advancing gestational age.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elevated maternal UA levels in early-to-mid gestation independently related to HDP risk, with subtype-specific and gestational-age\u2013dependent patterns. UA serves as a practical potential biomarker for early risk stratification and dynamic monitoring of women at risk for hypertensive complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1731576","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T06:34:47Z","timestamp":1765521287000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of early and mid-pregnancy maternal serum uric acid with hypertensive disorders of pregnancy"],"prefix":"10.3389","volume":"16","author":[{"given":"Chang","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruru","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinxin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/aog.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222","volume":"135","year":"2020","journal-title":"Obstetrics gynecology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e071653","DOI":"10.1136\/bmj-2022-071653","article-title":"Hypertensive disorders of pregnancy","volume":"381","author":"Wu","year":"2023","journal-title":"BMJ (Clinical Res ed)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2024.102473","article-title":"Preventing maternal morbidity and mortality from preeclampsia and eclampsia particularly in low- and middle-income countries","volume":"94","author":"Ngene","year":"2024","journal-title":"Best Pract Res Clin obstetrics gynaecology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccl.2020.09.005","article-title":"Hypertensive disorders of pregnancy","volume":"39","author":"Khedagi","year":"2021","journal-title":"Cardiol clinics"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-023-00417-6","article-title":"Pre-eclampsia","volume":"9","author":"Dimitriadis","year":"2023","journal-title":"Nat Rev Dis primers"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.12.092","article-title":"Long-term cardiovascular risks associated with adverse pregnancy outcomes: JACC review topic of the week","volume":"73","author":"Lane-Cordova","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2024.05.012","article-title":"Update on preeclampsia and hypertensive disorders of pregnancy","volume":"53","author":"Rosenberg","year":"2024","journal-title":"Endocrinol Metab Clinics North America"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14070890","article-title":"Iron-immune crosstalk at the maternal-fetal interface: emerging mechanisms in the pathogenesis of preeclampsia","volume":"14","author":"Zhong","year":"2025","journal-title":"Antioxidants (Basel Switzerland)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/biom13101519","article-title":"Exploring the multifaceted nexus of uric acid and health: A review of recent studies on diverse diseases","volume":"13","author":"Kuwabara","year":"2023","journal-title":"Biomolecules"},{"key":"B10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","article-title":"Regulation of uric acid metabolism and excretion","volume":"213","author":"Maiuolo","year":"2016","journal-title":"Int J Cardiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063188","article-title":"Uric acid and oxidative stress-relationship with cardiovascular, metabolic, and renal impairment","volume":"23","author":"Gherghina","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.118.11496","article-title":"Uric acid and hypertension because of arterial stiffness","volume":"72","author":"Kuwabara","year":"2018","journal-title":"Hypertension (Dallas Tex: 1979)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-023-01273-3","article-title":"Update in uric acid, hypertension, and cardiovascular diseases","volume":"46","author":"Kuwabara","year":"2023","journal-title":"Hypertension research: Off J Japanese Soc Hypertension"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/hjh.0000000000003472","article-title":"Serum uric acid to creatinine ratio and risk of preeclampsia and adverse pregnancy outcomes","volume":"41","author":"Piani","year":"2023","journal-title":"J hypertension"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.11.029","article-title":"Chronic hypertension and superimposed preeclampsia: screening and diagnosis","volume":"226","author":"Kametas","year":"2022","journal-title":"Am J obstetrics gynecology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.1090","article-title":"Plasma xanthine oxidase, superoxide dismutase and glutathione peroxidase activities and uric acid levels in severe and mild pre-eclampsia","volume":"22","author":"Yildirim","year":"2004","journal-title":"Cell Biochem Funct"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14080928","article-title":"Uric acid and preeclampsia: pathophysiological interactions and the emerging role of inflammasome activation","volume":"14","author":"Arias-S\u00e1nchez","year":"2025","journal-title":"Antioxidants (Basel Switzerland)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2022.2099254","article-title":"Relationship between maternal serum uric acid level and preeclampsia with or without severe features","volume":"42","author":"Sudjai","year":"2022","journal-title":"J obstetrics gynaecology: J Institute Obstetrics Gynaecology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2020.12.013","article-title":"Uric acid and cardiovascular disease: A clinical review","volume":"78","author":"Saito","year":"2021","journal-title":"J Cardiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-024-01295-3","article-title":"Hyperuricemia: an intriguing connection to metabolic syndrome, diabetes, kidney disease, and hypertension","volume":"26","author":"Vareldzis","year":"2024","journal-title":"Curr hypertension Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2005090949","article-title":"Uric acid and endothelial dysfunction in essential hypertension","volume":"17","author":"Zoccali","year":"2006","journal-title":"J Am Soc Nephrology: JASN"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1161\/hy1101.092839","article-title":"Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism","volume":"38","author":"Mazzali","year":"2001","journal-title":"Hypertension (Dallas Tex: 1979)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1159\/000452726","article-title":"Uric acid, vascular stiffness, and chronic kidney disease: is there a link","volume":"43","author":"Ramirez-Sandoval","year":"2017","journal-title":"Blood purification"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/15257770802138558","article-title":"Uric acid: the oxidant-antioxidant paradox","volume":"27","author":"Sautin","year":"2008","journal-title":"Nucleosides nucleotides Nucleic Acids"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-014-0239-5","article-title":"Uric acid induces oxidative stress via an activation of the renin-angiotensin system in 3T3-L1 adipocytes","volume":"48","author":"Zhang","year":"2015","journal-title":"Endocrine"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3282f240bf","article-title":"Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system","volume":"26","author":"Corry","year":"2008","journal-title":"J hypertension"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00283.2001","article-title":"Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism","volume":"282","author":"Mazzali","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.13888","article-title":"Salivary uric acid as a predictive test of preeclampsia, pregnancy-induced hypertension and preterm delivery: A pilot study","volume":"99","author":"P\u00fcschl","year":"2020","journal-title":"Acta obstetricia gynecologica Scandinavica"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19051496","article-title":"Oxidative stress in preeclampsia and placental diseases","volume":"19","author":"Aouache","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2007.11.001","article-title":"Uric acid as a pathogenic factor in preeclampsia","volume":"29","author":"Bainbridge","year":"2008","journal-title":"Placenta"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2010.262","article-title":"First trimester uric acid and adverse pregnancy outcomes","volume":"24","author":"Laughon","year":"2011","journal-title":"Am J hypertension"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200402000-00001","article-title":"Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link","volume":"22","author":"Kang","year":"2004","journal-title":"J hypertension"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1731576\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T06:34:48Z","timestamp":1765521288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1731576\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":33,"alternative-id":["10.3389\/fendo.2025.1731576"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1731576","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"article-number":"1731576"}}